A Systematic Review to Determine if Family History of Response to Medication Predicts Outcome in Mood Disorders.

IF 2.8 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Journal of Clinical Psychopharmacology Pub Date : 2025-07-01 Epub Date: 2025-05-09 DOI:10.1097/JCP.0000000000002011
Jeffrey J Rakofsky, Michael J Lucido, Boadie W Dunlop
{"title":"A Systematic Review to Determine if Family History of Response to Medication Predicts Outcome in Mood Disorders.","authors":"Jeffrey J Rakofsky, Michael J Lucido, Boadie W Dunlop","doi":"10.1097/JCP.0000000000002011","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose/background: </strong>Examining a patient's family history of medication response is a commonly used method to inform treatment selection. Though widely recommended, there are no published reviews that assess the validity of this approach when treating patients with affective disorders.</p><p><strong>Methods/procedures: </strong>All published studies in the form of case-control or randomized controlled trials that enrolled probands with either bipolar I or II depression or major depression and were written in English were included. Studies must have also included biological relatives and must have included at least 2 families. The authors compared the methodology of each trial to a hierarchy of study designs best suited to demonstrate the predictive ability of a family history of response to a medication.</p><p><strong>Findings/results: </strong>All studies involved only a small number of participants and none of the publications included in this review used a study design that reached the highest level of study quality needed to prove the link between 2 family members' likelihood of response to a medicine. Two studies had some elements of a level I study while the remaining studies were classified at level II or III of the study hierarchy.</p><p><strong>Implications/conclusions: </strong>Although small studies suggest that a family history of drug response can predict outcome in mood disorder patients, the designs of these studies do not confirm this in a definitive manner.</p>","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":"364-371"},"PeriodicalIF":2.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JCP.0000000000002011","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose/background: Examining a patient's family history of medication response is a commonly used method to inform treatment selection. Though widely recommended, there are no published reviews that assess the validity of this approach when treating patients with affective disorders.

Methods/procedures: All published studies in the form of case-control or randomized controlled trials that enrolled probands with either bipolar I or II depression or major depression and were written in English were included. Studies must have also included biological relatives and must have included at least 2 families. The authors compared the methodology of each trial to a hierarchy of study designs best suited to demonstrate the predictive ability of a family history of response to a medication.

Findings/results: All studies involved only a small number of participants and none of the publications included in this review used a study design that reached the highest level of study quality needed to prove the link between 2 family members' likelihood of response to a medicine. Two studies had some elements of a level I study while the remaining studies were classified at level II or III of the study hierarchy.

Implications/conclusions: Although small studies suggest that a family history of drug response can predict outcome in mood disorder patients, the designs of these studies do not confirm this in a definitive manner.

一项确定药物反应家族史是否能预测情绪障碍预后的系统综述。
目的/背景:检查患者的药物反应家族史是告知治疗选择的常用方法。虽然被广泛推荐,但没有发表的评论评估这种方法在治疗情感性障碍患者时的有效性。方法/程序:纳入所有已发表的病例对照或随机对照试验形式的研究,纳入双相I型或II型抑郁症或重度抑郁症先证者,并以英文撰写。研究还必须包括生物亲属,并且必须包括至少两个家庭。作者将每个试验的方法与研究设计的层次结构进行了比较,这些设计最适合于证明家族史对药物反应的预测能力。发现/结果:所有研究仅涉及少量参与者,本综述中纳入的出版物均未采用达到最高研究质量水平的研究设计,以证明两名家庭成员对药物的反应可能性之间的联系。两项研究具有一级研究的某些要素,而其余研究被分类为二级或三级研究。含义/结论:尽管小型研究表明药物反应家族史可以预测情绪障碍患者的预后,但这些研究的设计并不能明确地证实这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
3.40%
发文量
231
审稿时长
4-8 weeks
期刊介绍: Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信